Dr. Sarah J Watson, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1011 Lake St, Suite #216, Oak Park, IL 60301 Phone: 888-476-5171 |
Jason Winkelmann, ND, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 503 Madison St, Oak Park, IL 60302 Phone: 847-814-2096 |
Dr. Cheryl E Haugh, D.C. Chiropractor - Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 831 S Oak Park Ave, Oak Park, IL 60304 Phone: 708-848-9900 Fax: 708-848-9902 |
Oak Park Sports Medicine Chiropractor - Orthopedic Medicare: Not Enrolled in Medicare Practice Location: 1144 Lake St, 203, Oak Park, IL 60301 Phone: 708-406-9459 |
Dr. Kelly Opron, Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 147 Harrison St # B, Oak Park, IL 60304 Phone: 708-613-0615 Fax: 708-294-3835 |
Dr. Karishma Riman, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1011 Lake St Ste 308, Oak Park, IL 60301 Phone: 312-437-1129 |
Dr. Farris Patterson Iii, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 910 S Grove Ave, Oak Park, IL 60304 Phone: 708-358-1614 Fax: 708-358-1623 |
News Archive
Only half of younger heart attack patients believed that they were at risk before the onset of an attack, and even fewer discussed health risks with their doctors, according to Yale School of Public Health researchers. The findings were more pronounced among women than men.
HemaQuest Pharmaceuticals, a clinical stage biotechnology company developing compounds to treat sickle cell disease, beta thalassemia and EBV-related cancers, announced today the closing of a $12M Series B financing led by new investor, Aberdare Ventures. HemaQuest's investor syndicate includes Aberdare Ventures, De Novo Ventures, Forward Ventures and Lilly Ventures.
New results from a multicenter study led by Johns Hopkins show that patients who got an experimental clot-busting treatment for a particularly lethal form of stroke were not only dramatically more likely to survive but also continued to shed lingering disabilities six months later.
A one-time injection of an experimental stem cell therapy can repair brain damage and improve memory function in mice with conditions that replicate human strokes and dementia, a new UCLA study finds.
Dr. Jim Evans, an expert in gene patenting and genetics policy who has led a program to educate federal judges about the intricacies of genetics and genetic policy, says the ruling by United States District Court Judge Robert Sweet that invalidated seven patents related to the BRCA 1 and BRCA 2 genes "came as a surprise to everybody. It's really quite unusual for plaintiffs to get a summary judgment."
› Verified 8 days ago